We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
-3.92%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$2.82B
AUM Growth
-$152M
Cap. Flow
-$15M
Cap. Flow %
-0.53%
Top 10 Hldgs %
31.4%
Holding
281
New
12
Increased
92
Reduced
119
Closed
12

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$27.6M
2
GNRC icon
Generac Holdings
GNRC
+$8.45M
3
FISV
Fiserv Inc
FISV
+$5.42M
4
TFI icon
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
+$5.18M
5
IGV icon
iShares Expanded Tech-Software Sector ETF
IGV
+$3.71M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$16.4M
2
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$11.5M
3
SEIC icon
SEI Investments
SEIC
+$8.37M
4
TTD icon
Trade Desk
TTD
+$5.74M
5
DIS icon
Walt Disney
DIS
+$4.22M

Sector Composition

Rank Sector Weight
1 Technology 24.95%
2 Financials 16.33%
3 Healthcare 11.16%
4 Consumer Discretionary 8.86%
5 Communication Services 5.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EDIT icon
251
Editas Medicine
EDIT
$396M
$192K 0.01%
15,710
-2,000
-11% -$31.2K
BAC icon
252
CALL
Bank of America
BAC
$435B
$166K 0.01%
5,500
– –
LMDX
253
DELISTED
LumiraDx Limited Common Shares
LMDX
$148K 0.01%
+145,300
New +$241K
MSFT icon
254
CALL
Microsoft
MSFT
$3.45T
$116K ﹤0.01%
500
– –
VMEO
255
DELISTED
Vimeo
VMEO
$112K ﹤0.01%
28,105
– –
PROF
256
Profound Medical
PROF
$268M
$92K ﹤0.01%
22,700
+5,000
+28% +$33.7K
WFC icon
257
CALL
Wells Fargo
WFC
$261B
$80K ﹤0.01%
2,000
– –
AGEN
258
Agenus
AGEN
$312M
$68K ﹤0.01%
1,678
– –
DNA icon
259
Ginkgo Bioworks
DNA
$528M
$58K ﹤0.01%
462
– –
DIS icon
260
CALL
Walt Disney
DIS
$167B
$47K ﹤0.01%
500
– –
NAGE
261
Niagen Bioscience
NAGE
$271M
$47K ﹤0.01%
37,925
+1,641
+5% +$2.64K
F icon
262
CALL
Ford
F
$58.5B
$44K ﹤0.01%
4,000
– –
GS icon
263
Goldman Sachs
GS
$300B
$44K ﹤0.01%
150
-7
-4% -$2.27K
DAKT icon
264
Daktronics
DAKT
$955M
$41K ﹤0.01%
40,989
– –
KLR
265
DELISTED
Kaleyra, Inc.
KLR
$32K ﹤0.01%
9,500
– –
PHUN icon
266
Phunware
PHUN
$43.1M
$18K ﹤0.01%
300
– –
CATX icon
267
Perspective Therapeutics
CATX
$332M
$13K ﹤0.01%
5,482
– –
EVGN icon
268
Evogene
EVGN
$5.7M
$12K ﹤0.01%
1,400
– –
CGEN icon
269
Compugen
CGEN
$222M
$10K ﹤0.01%
15,720
– –
AMD icon
270
Advanced Micro Devices
AMD
$776B
– –
-7,473
Closed -$571K
CL icon
271
Colgate-Palmolive
CL
$73.1B
– –
-2,776
Closed -$222K
FTNT icon
272
Fortinet
FTNT
$119B
– –
-3,910
Closed -$221K
IWS icon
273
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
– –
-2,068
Closed -$210K
JPIN icon
274
JPMorgan Diversified Return International Equity ETF
JPIN
$368M
– –
-36,269
Closed -$1.77M
DFTX
275
Definium Therapeutics
DFTX
$5.78B
– –
-1,467
Closed -$14K
8 9 10
11
12

Similar funds

AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
GFM
GF Fund Management Guangzhou, China $5.98B AUM 80.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Crestwood Advisors Group's Q3 2022 Portfolio in Review

As of Q3 2022, Crestwood Advisors Group held 281 positions worth $2.82B, down 5.1% from $2.97B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Crestwood Advisors Group's Q3 2022 filing shows 12 new, 92 increased, 119 reduced and 12 closed positions. Its largest new stake was Applied Materials: 286,747 shares worth $23.5M. The largest sale was Accenture, an estimated $16.4M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Crestwood Advisors Group's largest Q3 2022 buy was Applied Materials: 286,747 shares worth $23.5M.
  • Crestwood Advisors Group added most to Generac Holdings in Q3 2022, an estimated $8.45M increase.
  • Crestwood Advisors Group's biggest Q3 2022 reduction was Accenture, cutting an estimated $16.4M.
  • Crestwood Advisors Group fully exited JPMorgan Diversified Return International Equity ETF in Q3 2022, selling an estimated $1.77M.
  • Crestwood Advisors Group's ten largest holdings make up 31% of its $2.82B portfolio in Q3 2022.
  • Crestwood Advisors Group opened 12 new positions and closed 12 in Q3 2022.
  • Crestwood Advisors Group's portfolio value fell 5.1% quarter-over-quarter to $2.82B.

Based on Crestwood Advisors Group's 13F filing for Q3 2022, filed 26 Oct 2022.